Navigation Links
Abbott Research Group, Inc. Launches New Product - WaterWorks
Date:3/1/2010

FDA Cleared WaterWorks Safely Eliminates Feminine Odor

(PRWEB) March 1, 2010 -- Abbott Research Group, Inc. announces the FDA clearance of WaterWorks, their medical device clinically proven to eliminate vaginal odor. WaterWorks is the only FDA cleared product to safely and effectively eliminate vaginal odor. It is available OTC, so no prescription is required. With four US patents plus patents in Europe, Canada and Australia, this comfortable, safe, natural and effective solution aids in maintaining a healthy pH level and does not alter the vaginal ecosystem, unlike other douches that contain harsh chemicals such as Octoxynol-9.

WaterWorks has also received certification from Health Canada, the federal department that regulates the safety and efficacy of medical devices in Canada. Now available for distribution via Amazon.com, WaterWorks has also obtained the CE Mark for distribution in Europe. In response to consumer demand, WaterWorks is also now available online in the United Kingdom.

WaterWorks has been carefully researched for over six years to guarantee its safety and has been clinically proven efficacious using only low-pressure tap water and medical grade stainless steel. Both medical professionals and consumers alike are praising the positive effects of this innovative vaginal cleansing system. Common user testimonials boast a resounding thank you and reports of helping resolve vaginal odor and discharge issues among women seeking help.

“We are so excited to hear the enthusiastic responses from women around the world who use WaterWorks regularly. It is rewarding to sell a product that makes women feel fresh, clean and confident,” says Chun Lim Abbott, CEO of Abbott Research Group, Inc.

WaterWorks’ medical grade, lightweight stainless steel nozzle and low-pressure water combination is designed for easy, reusable use in the shower as part of a daily routine. A custom-designed water container is attached to the device via a latex-free hose. The water container and hose are biocompatible with the delicate vaginal tissue, as proven through extensive clinical testing. The water container is filled with approximately 32 ounces of body temperature tap water and placed at eye level so the natural gravity flow of water gently washes the vagina. Although results are typically expected within two weeks, users notice results within one to three days.

Similar to the stainless steel soap bar and tap water used by chefs as the most effective way of eradicating unwanted scents such as garlic, onions and fish from the hands of food preparers, WaterWorks uses a similar science to remove unwanted vaginal odor.

WaterWorks’ patented shape also has special channels, which prevent damming up of the water and enhance rapid drainage. The gentle flow of water is directed downward, which prevents bad bacteria from being pushed farther into the vagina. The patented design addresses the concerns doctors have with other over the counter douching products.

“When I get up every morning, I really relish looking at comments from satisfied customers. It is rewarding to see our years of scientific research, new product development and clinical trials come to fruition in helping the women who need this product the most. WaterWorks has truly been life-changing for its users and we want to keep spreading the word about the success of the product so we can continue to make it available to women internationally,” says Dominic Abbott, COO of Abbott Research Group, Inc.

In a recent customer poll, the top three reasons why women purchased WaterWorks were that it is all natural and chemical-free, they felt it was an effective solution to their problem and their doctor recommended using WaterWorks. For additional product details regarding WaterWorks, visit www.WaterWorksHealth.com

About Abbott Research Group, Inc.:
Abbott Research Group, Inc., doing business as ARG, is headquartered in RIDC Park in O’Hara Township, a suburb of Pittsburgh, PA. In 1999, ARG was created to research and develop personal healthcare products, completely by company-funded medical research. ARG is initially focusing on women’s health issues developing intellectual property and publishing research along the way to an FDA cleared medical product.

ARG is a self-funded business venture of Dominic and Chun Lim Abbott. Mr. Abbott has successfully started and run several successful businesses over the past 40 years and possesses an international business acumen that has led the way to unique visionary ideas. ARG is committed to clinical research, leading to development of products of only the highest quality. Awarded the International Standards Operation (ISO) 13485-2003 in October 2007, ARG attained certification for the highest standard of quality and holds its manufacturing facility to the same standards for quality. ARG products and services empower consumers to make educated decisions that will improve their personal healthcare. For more information regarding ARG, visit www.AbbottResearchGroup.com

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3395244.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Abbott Announces 10 Percent Increase in Quarterly Dividend
2. Abbott Completes Acquisition of Solvay Pharmaceuticals
3. Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
4. Abbott to Provide $1 Million in Funding, Products to Help Address Health Needs in Haiti
5. Feeding America and Abbott Transform Disaster Preparedness Into Hunger Relief
6. Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems
7. Abbott Declares 344th Consecutive Quarterly Dividend
8. Abbott Statement on ARBITER 6 - HALTS Results and Abbotts Niaspan (niacin extended-release)
9. Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
10. Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois
11. Abbott Again Honored for Offering One of the Top 10 Leading Workplaces
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Abbott Research Group, Inc. Launches New Product - WaterWorks 
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: